NCT06793618

Brief Summary

A quantitative study, true experimental, posttest-only design has been used for the current study. one intervention (the Z-track technique) and one control group involved in the study. The primary outcome measure is the Neonatal/Infant Pain Scale to be used immediately after intramuscular injections to measure the pain level among neonates.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
147

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 24, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 27, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2024

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

January 20, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 27, 2025

Completed
Last Updated

February 4, 2025

Status Verified

February 1, 2025

Enrollment Period

1 month

First QC Date

January 20, 2025

Last Update Submit

February 1, 2025

Conditions

Keywords

Painnon-pharmacological pain managment

Outcome Measures

Primary Outcomes (1)

  • Neonatal/ Infant Pain Scale

    A scale developed specifically for newborn infants. Consists of 6 criterion (Face Expression, cry, Patterns of Breathing, leg and arm movements, Arousal status) Recommended for children less than 1 year old.

    from the process of enrollment at the post-natal ward until the IM injection is administered (usually takes less than 1 hour)

Study Arms (2)

Z-track technique

ACTIVE COMPARATOR

To perform the zeta-track technique: In this method, the neonates are in supine position, the skin is moved and held from the injection site 2 to 3 cm to the side or downward using the non- dominant hand, to ensure that blood vessel wasn't penetrated aspiration on the syringe must perceive the injection and then the medication is to be injected slowly. Researcher assistant that is unaware of the injection method performs the recording of the pain intensity and leakage diameter on the observation form.

Other: Z-track technique

Control group

NO INTERVENTION

the neonates receive the intramuscular injection using the conventional method and protocol used in the postnatal ward without any interventions

Interventions

In this method, the neonates are in supine position, the skin is moved and held from the injection site 2 to 3 cm to the side or downward using the non- dominant hand, to ensure that blood vessel wasn't penetrated aspiration on the syringe must perceive the injection and then the medication is to be injected slowly. Researcher assistant that is unaware of the injection method performs the recording of the pain intensity and leakage diameter on the observation form.

Z-track technique

Eligibility Criteria

Age5 Minutes - 2 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Neonates delivered through cesarean section
  • Apgar score of 8 or more
  • Weight between 2500 - 3500 grams
  • neonates receiving IM injections
  • Males / females
  • term neonates between 37th and 42nd week of gestation

You may not qualify if:

  • Congenital anomalies
  • neonates who received intramuscular injection such as the Hepatitis B vaccine
  • Low birth weight
  • Preterms
  • Neural tube defects
  • neonates who are of normal vaginal delivery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Feminine and Children Educational Hospital

Samawah, Muthanna Governorate, 66001, Iraq

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A randomized control trial with one intervention and one control group. post-test only
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Academic Nurse

Study Record Dates

First Submitted

January 20, 2025

First Posted

January 27, 2025

Study Start

November 24, 2024

Primary Completion

December 27, 2024

Study Completion

December 28, 2024

Last Updated

February 4, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations